Mullerian duct
Summary
The Müllerian (paramesonephric) ducts are embryonic paired ducts that, in the absence of AMH (anti-Müllerian hormone) and SRY/testosterone effects, develop into the fallopian tubes, uterus, cervix, and upper one-third of the vagina. In males, Sertoli cells secrete AMH, causing Müllerian duct regression. Failure of fusion or development causes anomalies such as bicornuate uterus, uterine didelphys, and Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.
Detail
**Embryology** - Both sexes initially have two sets of ducts (indifferent stage): Wolffian (mesonephric) and Müllerian (paramesonephric). - Müllerian ducts arise from invagination of coelomic (intermediate mesoderm-derived) epithelium lateral to the mesonephric ducts, around week 6. - **Female (no SRY, no AMH):** Müllerian ducts persist. The unfused cranial portions form the fallopian tubes (oviducts). The caudal portions fuse in the midline (uterovaginal primordium) to form the uterus, cervix, and upper 1/3 of the vagina. The Wolffian ducts regress due to lack of testosterone. The lower 2/3 of the vagina comes from the urogenital sinus (sinovaginal bulbs). Note: ovaries are NOT Müllerian derivatives (they come from gonadal ridge/genital ridge). - **Male (SRY → SOX9 → Sertoli cells):** Sertoli cells secrete AMH (Müllerian-inhibiting substance), which causes ipsilateral Müllerian duct regression. Leydig cells make testosterone, which stabilizes the Wolffian ducts (epididymis, vas deferens, seminal vesicles, ejaculatory duct). DHT drives external genitalia and prostate. Remnants: appendix testis and prostatic utricle.
**Mnemonic:** "Müllerian = Mother (female structures)"; Sertoli cells "Suppress" Müllerian ducts.
**Clinical correlations** 1. **Müllerian agenesis / MRKH syndrome:** Primary amenorrhea with normal secondary sexual characteristics (normal ovaries and hormones), 46,XX, absent or hypoplastic uterus and upper vagina (blind-ending vaginal pouch). Associated with renal anomalies (unilateral renal agenesis, horseshoe/pelvic kidney) and skeletal anomalies. Ultrasound or MRI shows absent uterus. Treatment: vaginal dilation or surgical neovagina creation. Differential: androgen insensitivity syndrome (46,XY, absent uterus, but scant/absent pubic and axillary hair, and testes present). 2. **Fusion defects (lateral fusion):** Uterus didelphys (complete nonfusion, two uteri/cervices, often double vagina), bicornuate uterus (partial fusion failure), septate uterus (failure of septum resorption; most common anomaly, highest risk of recurrent pregnancy loss; treated with hysteroscopic resection), unicornuate uterus (one duct fails to develop). Complications: recurrent miscarriage, preterm labor, malpresentation (breech), infertility, and obstructed menstrual flow (e.g., hematometra, cyclic pain with a noncommunicating horn). 3. **Persistent Müllerian duct syndrome (PMDS):** 46,XY male with normal virilization but retained uterus and fallopian tubes due to AMH or AMH receptor (AMHR2) mutations. Often presents as cryptorchidism or an inguinal hernia containing a uterus (found incidentally at surgery). 4. **Swyer syndrome (46,XY gonadal dysgenesis):** SRY absent or mutated → no testes → no AMH → Müllerian structures develop (uterus present), but streak gonads give no estrogen, causing primary amenorrhea and absent breast development; high gonadal tumor risk (dysgerminoma, gonadoblastoma), so gonadectomy is indicated. 5. **Complete androgen insensitivity (46,XY):** Testes make AMH → no Müllerian structures (no uterus, short blind vagina); testosterone cannot act → female external phenotype; testes are intra-abdominal/inguinal (risk of malignancy; removed after puberty). 6. **DES (diethylstilbestrol) exposure in utero:** Müllerian anomalies (T-shaped uterus), clear cell adenocarcinoma of the vagina/cervix, and infertility/ectopic pregnancy risk. 7. **Müllerian-derived tumors/tissue:** The upper genital tract epithelium can give rise to serous, endometrioid, and clear cell ovarian carcinomas (secondary Müllerian system concept). Also relevant: AMH is used as a marker of ovarian reserve and a tumor marker for granulosa cell tumors.
**High-yield comparison** | Feature | Müllerian (paramesonephric) | Wolffian (mesonephric) | |---|---|---| | Persists with | Absence of AMH (female) | Testosterone (male) | | Derivatives | Fallopian tubes, uterus, cervix, upper vagina | Epididymis, ductus deferens, seminal vesicles, ejaculatory duct (ESSD mnemonic: Epididymis, Seminal vesicles, Ejaculatory duct, Ductus deferens) | | Regression mediated by | AMH from Sertoli cells | Lack of testosterone | | Female remnants | — | Gartner duct cyst, epoophoron, paroophoron |
**Associated developmental link:** Müllerian and renal development are closely related (both derive from intermediate mesoderm), so Müllerian anomalies should prompt a renal imaging workup. Genes involved include WNT4, HOXA10/HOXA13, PAX2, and LHX1.
Sources
- First Aid for the USMLE Step 1 (Embryology: Female/Male genital embryology)
- Langman's Medical Embryology (Urogenital System)
- Robbins & Cotran Pathologic Basis of Disease (Female Genital Tract)
- Pathoma (Fundamentals of Pathology) – Reproductive/Embryology sections
- Williams Gynecology (Congenital Anomalies of the Female Reproductive Tract)
- UWorld Step 1/Step 2 CK Question Banks (Reproductive & Endocrine)
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.